Federated Hermes
NERV icon

Federated Hermes’s Minerva Neurosciences NERV Stock Holding History

Federated Hermes’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.8M Sell
5,113,224
-258,551
-5% -$1.48M 0.05% 372
2025
Q4 		$19.5M Buy
5,371,775
+4,020,500
+298% +$14.9M 0.03% 463
2025
Q3 		$2.86M Hold
1,351,275
– – 0.01% 854
2025
Q2 		$2.32M Hold
1,351,275
– – ﹤0.01% 895
2025
Q1 		$2.3M Hold
1,351,275
– – 0.01% 905
2024
Q4 		$3M Hold
1,351,275
– – 0.01% 846
2024
Q3 		$3.61M Hold
1,351,275
– – 0.01% 795
2024
Q2 		$4.31M Hold
1,351,275
– – 0.01% 745
2024
Q1 		$3.49M Hold
1,351,275
– – 0.01% 802
2023
Q4 		$8.31M Hold
1,351,275
– – 0.02% 601
2023
Q3 		$9.32M Hold
1,351,275
– – 0.02% 546
2023
Q2 		$9.9M Buy
1,351,275
+150,000
+12% +$792K 0.02% 542
2023
Q1 		$1.92M Hold
1,201,275
– – ﹤0.01% 969
2022
Q4 		$1.91M Hold
1,201,275
– – 0.01% 925
2022
Q3 		$11.1M Hold
1,201,275
– – 0.03% 508
2022
Q2 		$3.98M Hold
1,201,275
– – 0.01% 738
2022
Q1 		$7.98M Hold
1,201,275
– – 0.02% 663
2021
Q4 		$7.7M Hold
1,201,275
– – 0.01% 724
2021
Q3 		$16.7M Hold
1,201,275
– – 0.03% 522
2021
Q2 		$22.3M Hold
1,201,275
– – 0.04% 451
2021
Q1 		$28.1M Hold
1,201,275
– – 0.05% 410
2020
Q4 		$22.5M Hold
1,201,275
– – 0.05% 442
2020
Q3 		$30.6M Hold
1,201,275
– – 0.07% 313
2020
Q2 		$34.7M Hold
1,201,275
– – 0.09% 273
2020
Q1 		$57.9M Hold
1,201,275
– – 0.17% 139
2019
Q4 		$68.3M Buy
1,201,275
+18,035
+2% +$795K 0.15% 159
2019
Q3 		$73.4M Buy
1,183,240
+232,579
+24% +$13.2M 0.18% 131
2019
Q2 		$42.8M Buy
950,661
+8,750
+0.9% +$438K 0.1% 214
2019
Q1 		$59.2M Hold
941,911
– – 0.15% 153
2018
Q4 		$50.8M Hold
941,911
– – 0.14% 157
2018
Q3 		$94.6M Hold
941,911
– – 0.22% 99
2018
Q2 		$62.2M Hold
941,911
– – 0.18% 110
2018
Q1 		$47.1M Hold
941,911
– – 0.14% 130
2017
Q4 		$45.6M Hold
941,911
– – 0.13% 137
2017
Q3 		$57.3M Hold
941,911
– – 0.16% 113
2017
Q2 		$66.7M Buy
941,911
+145,296
+18% +$9.4M 0.19% 103
2017
Q1 		$51.6M Buy
796,615
+1,785
+0.2% +$139K 0.15% 131
2016
Q4 		$74.7M Hold
794,830
– – 0.22% 84
2016
Q3 		$89.8M Buy
794,830
+37,500
+5% +$3.64M 0.26% 70
2016
Q2 		$61.9M Buy
757,330
+125,000
+20% +$7.95M 0.18% 93
2016
Q1 		$31.1M Buy
632,330
+303,951
+93% +$13M 0.1% 180
2015
Q4 		$15.9M Hold
328,379
– – 0.05% 327
2015
Q3 		$13.8M Buy
328,379
+15,053
+5% +$691K 0.04% 369
2015
Q2 		$14.5M Hold
313,326
– – 0.04% 392
2015
Q1 		$8.66M Buy
313,326
+309,645
+8,412% +$12.8M 0.03% 487
2014
Q4 		$178K Buy
+3,681
New +$140K ﹤0.01% 1511

Other funds holding NERV

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Federated Hermes's NERV Position: Q1 2026 in Review

Federated Hermes reduced its Minerva Neurosciences (NERV) stake by 4.8% in Q1 2026, selling an estimated $1.48M and leaving 5,113,224 shares worth $30.8M. The position accounts for 0.05% of the portfolio, ranked #372.

Federated Hermes first reported a position in NERV in Q4 2014 and has held it in 46 quarters since. The position peaked at $94.6M in Q3 2018. 47 funds tracked by Wall St. Rank hold NERV as of Q1 2026.

  • Federated Hermes held 5,113,224 shares of Minerva Neurosciences worth $30.8M as of Q1 2026.
  • Federated Hermes sold 258,551 Minerva Neurosciences shares in Q1 2026, an estimated $1.48M.
  • Minerva Neurosciences made up 0.05% of Federated Hermes's portfolio in Q1 2026, its #372 holding.
  • Federated Hermes first reported a position in Minerva Neurosciences in Q4 2014 and has held it in 46 quarters since.
  • Federated Hermes's Minerva Neurosciences position peaked at $94.6M in Q3 2018.
  • 47 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.